Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Copper Bis(histidinate)
2. Copper Bis(histidinate), (l,trans)-isomer
3. Copper Bis(histidinate), N,o(d)-isomer
4. Copper Bis(histidinate), N,o(l)-isomer
5. Copper Bishistidinate
6. Cu(his)2
7. Cu-his
8. Histidine, Copper(1+) Salt (1:1)
1. Copper Bis(histidinate)
2. 12561-67-0
3. Bishistidine Copper(ii) Salt
4. 9078k3mo9u
5. Copper, Bis(l-histidinato-n,o)-
6. Copper Histidinate
7. L-histidine, Copper(2+) Salt (2:1)
8. Copper Bishistidinate
9. Cu(his)2
10. 13870-80-9
11. L-histidine, Copper Complex
12. Copper, Bis(l-histidinato)-
13. Bis(l-histidinato-n,o)copper
14. Schembl895831
15. Unii-9078k3mo9u
16. Dtxsid30154803
17. Copper, Bis(l-histidinato-n,n3,o)-
18. Copper, Bis(l-histidinato-kappan,kappao)-
19. J1.412.545k
20. Copper;(2s)-2-amino-3-(1h-imidazol-5-yl)propanoate
21. Q27271298
22. Copper, Bis(l-histidinato-.kappa.n,.kappa.o)-
| Molecular Weight | 371.84 g/mol |
|---|---|
| Molecular Formula | C12H16CuN6O4 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 371.052900 g/mol |
| Monoisotopic Mass | 371.052900 g/mol |
| Topological Polar Surface Area | 190 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 145 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
ABOUT THIS PAGE
A Copper Histidine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Copper Histidine, including repackagers and relabelers. The FDA regulates Copper Histidine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Copper Histidine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Copper Histidine supplier is an individual or a company that provides Copper Histidine active pharmaceutical ingredient (API) or Copper Histidine finished formulations upon request. The Copper Histidine suppliers may include Copper Histidine API manufacturers, exporters, distributors and traders.
Copper Histidine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Copper Histidine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Copper Histidine GMP manufacturer or Copper Histidine GMP API supplier for your needs.
A Copper Histidine CoA (Certificate of Analysis) is a formal document that attests to Copper Histidine's compliance with Copper Histidine specifications and serves as a tool for batch-level quality control.
Copper Histidine CoA mostly includes findings from lab analyses of a specific batch. For each Copper Histidine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Copper Histidine may be tested according to a variety of international standards, such as European Pharmacopoeia (Copper Histidine EP), Copper Histidine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Copper Histidine USP).
LOOKING FOR A SUPPLIER?
